Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Device Daily Bulletin > ImaCor Receives CE Mark for ClariTEE Probe

FDAnews Device Daily Bulletin

July 20, 2011 | Vol. 8 No. 141

ImaCor Receives CE Mark for ClariTEE Probe

ImaCor has received a CE Mark for its ClariTEE Probe and Zura Systems, allowing for the marketing of these systems in Europe. ClariTEE is used to provide blood flow monitoring to seriously ill patients. It remain indwelling for up to 72 hours.

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Canada Updates Recognized Standards List Argentina Eases Device Registration for Some Products, Impact Unclear Argentina Eases Device Registration for Some Products, Impact Unclear Russia’s New Device Registration Requirements: Still Not User-Friendly

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.